Literature DB >> 34041362

No findings of SARS-CoV-2 in conjunctival swabs from patients at an emergency outpatient ophthalmological healthcare facility in a Swedish county hospital: a cross-sectional study.

Elisabet Granstam1,2, Anders Krifors1,3, Elisabeth Freyhult4, Hanna Åkerblom2.   

Abstract

BACKGROUND: COVID-19 is caused by SARS-CoV-2. Virus has been found in conjunctiva of hospitalised patients with COVID-19. Conjunctivitis has also been reported as a presenting symptom of disease.
OBJECTIVE: The aims of the study were to investigate the prevalence of SARS-CoV-2 in the conjunctiva and throat among patients presenting at the emergency outpatient ophthalmological healthcare facility at a county hospital along with investigating the seroprevalence of SARS-CoV-2 among staff at the department. METHODS AND ANALYSIS: Swabs from conjunctiva and throat of patients were analysed with real-time reverse transcriptase PCR (RT-PCR) for SARS-CoV-2. Blood samples for serological analysis were obtained from staff. A questionnaire was used to investigate symptoms associated with COVID-19 during the last 3 months as well as symptoms for which the patients were seeking ophthalmological healthcare.
RESULTS: In total, 68 patients and 70 individuals from the staff were included in the study. Conjunctivitis was observed in 7% of patients. One patient, presenting with reduced visual acuity due to preretinal haemorrhage in the macula, was positive for SARS-CoV-2 in throat swab. Contact tracing was negative. All other RT-PCR tests were negative. Seropositivity for SARS-CoV-2 was found in 4% of staff.
CONCLUSIONS: Our study demonstrated low prevalence of SARS-CoV-2 among patients as well as low seroprevalence of SARS-CoV-2 IgG-antibodies among staff at the ophthalmological ward. The risk for contracting COVID-19 at the department was small. Follow-up investigation is planned. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  conjunctiva; infection

Year:  2021        PMID: 34041362      PMCID: PMC7938470          DOI: 10.1136/bmjophth-2020-000616

Source DB:  PubMed          Journal:  BMJ Open Ophthalmol        ISSN: 2397-3269


  15 in total

1.  Acute Macular Neuroretinopathy Associated with Acute Influenza Virus Infection.

Authors:  Imran Ashfaq; Maria Vrahimi; Sheila Waugh; Taha Soomro; Michael E Grinton; Andrew C Browning
Journal:  Ocul Immunol Inflamm       Date:  2019-11-07       Impact factor: 3.070

2.  Retinal findings in hospitalised patients with severe COVID-19.

Authors:  Leonardo Amarante Pereira; Larissa Caroline Mansano Soares; Priscila Alves Nascimento; Luciano Rabello Netto Cirillo; Hebert Toshiaki Sakuma; Glaucia Luciano da Veiga; Fernando Luiz Afonso Fonseca; Vagner Loduca Lima; Julio Zaki Abucham-Neto
Journal:  Br J Ophthalmol       Date:  2020-10-16       Impact factor: 4.638

3.  SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.

Authors:  Ann-Sofie Rudberg; Sebastian Havervall; Anna Månberg; August Jernbom Falk; Katherina Aguilera; Henry Ng; Lena Gabrielsson; Ann-Christin Salomonsson; Leo Hanke; Ben Murrell; Gerald McInerney; Jennie Olofsson; Eni Andersson; Cecilia Hellström; Shaghayegh Bayati; Sofia Bergström; Elisa Pin; Ronald Sjöberg; Hanna Tegel; My Hedhammar; Mia Phillipson; Peter Nilsson; Sophia Hober; Charlotte Thålin
Journal:  Nat Commun       Date:  2020-10-08       Impact factor: 14.919

4.  Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease.

Authors:  Lu Chen; Meizhou Liu; Lei Liu; Guoming Zhang; Jiantao Wang; Zheng Zhang; Kun Qiao; Ting Huang; Miaohong Chen; Na Xin; Zuliang Huang
Journal:  Br J Ophthalmol       Date:  2020-04-07       Impact factor: 4.638

5.  Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle.

Authors:  Hongzhou Lu; Charles W Stratton; Yi-Wei Tang
Journal:  J Med Virol       Date:  2020-02-12       Impact factor: 2.327

6.  ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection.

Authors:  Lingli Zhou; Zhenhua Xu; Gianni M Castiglione; Uri S Soiberman; Charles G Eberhart; Elia J Duh
Journal:  Ocul Surf       Date:  2020-06-13       Impact factor: 5.033

7.  Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.

Authors:  Ping Wu; Fang Duan; Chunhua Luo; Qiang Liu; Xingguang Qu; Liang Liang; Kaili Wu
Journal:  JAMA Ophthalmol       Date:  2020-05-01       Impact factor: 7.389

8.  Conjunctivitis can be the only presenting sign and symptom of COVID-19.

Authors:  Sergio Zaccaria Scalinci; Edoardo Trovato Battagliola
Journal:  IDCases       Date:  2020-04-24

Review 9.  SARS: epidemiology.

Authors:  Moira Chan-Yeung; Rui-Heng Xu
Journal:  Respirology       Date:  2003-11       Impact factor: 6.424

10.  Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19.

Authors:  Nan Hong; Wangshu Yu; Jianhua Xia; Ye Shen; Maurice Yap; Wei Han
Journal:  Acta Ophthalmol       Date:  2020-04-26       Impact factor: 3.761

View more
  1 in total

Review 1.  How should we measure intraocular pressure in the era of coronavirus disease 2019? Balancing infectious risk, cleaning requirements, and accuracy.

Authors:  Christine A Petersen; Andrew Chen; Philip P Chen
Journal:  Curr Opin Ophthalmol       Date:  2022-03-01       Impact factor: 3.761

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.